Revium Rx (RVRC) Total Non-Current Liabilities (2025 - 2026)
Revium Rx (RVRC) posted Total Non-Current Liabilities of $46000.0 for Q4 2025.
Revium Rx (RVRC) Total Non-Current Liabilities (2025 - 2026) Analysis & Trends
Revium Rx has reported Total Non-Current Liabilities for 1 years, with the latest figure at $46000.0 in Q4 2025.
- Quarterly Total Non-Current Liabilities changed N/A year-over-year to $46000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $46000.0 (changed N/A YoY) and the FY2025 annual result came in at $46000.0, changed N/A from the prior year.
- Total Non-Current Liabilities steadied at $46000.0 in Q4 2025 per RVRC's latest filing.
- Over five years, Total Non-Current Liabilities peaked at $46000.0 in Q4 2025 and troughed at $46000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | 1.79 Bn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 3.85 Bn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 1.12 Bn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | 197.96 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | - |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | 702.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 1.88 Bn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 157.93 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | 64.43 Mn |
| 10 | Revium Rx | 101.42 Mn | 99.91 Mn | - | 619,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 619,000.00 |
| Dec 31, 2025 | 46,000.00 |